The NHS Breast Screening Programme responds to a new study comparing MRI with mammography

NHS Cancer Screening Programme Logo
Feedback and Enquires to the NHS Cancer Screening Programmes
NHS Cancer Screening
NHS Cancer Screening Press Room
NHS Breast Screening Programme
NHS Cervical Screening Programme
NHS Bowel Cancer Screening Programme
NHS Prostate Cancer Risk Management

Breast Screening Annual Review (UK)
Breast screening statistics
Breast Screening Equipment Guidance

Research Literature Online Database

Statement published 10th August, 2007

A Lancet study published 10 August 2007 found MRI scans are far better at detecting aggressive breast cancers at an early stage than standard mammograms. It claims that that X-ray based screening detects only 56 per cent of the early signs of a form of the disease.

But the University of Bonn team found MRI, more typically used for brain scans, picked up 92 per cent of lesions.

The study, of more than 7,300 women, focused on a very early-stage form of breast cancer called ductal carcinoma in situ (DCIS), which affects the milk ducts in the breast.

However, MRI scans are rarely used in breast clinics, and then usually only as a back-up to conventional scans.

The researchers are calling for greater use to be made of MRI in the detection of breast cancer.

NHS Cancer Screening Programmes Director, Julietta Patnick, said:

"The NHS Cancer Screening Programmes welcomes new research into screening for breast cancer. Detection of DCIS presents difficult issues for both women and their doctors as there are many uncertainties involved in the prognosis and management of the disease. The Programme uses mammography to screen all women in the UK aged 50 or more for breast cancer. The results in The Lancet are not representative of the screening population, and so have to be interpreted with care."

For further information, please contact the NHS Cancer Screening Programmes' press office on 020 7400 4499 or e-mail [email protected].


Search this site for:
Breast Screening Publications Index

Breast screening programme index

What happens at a
breast screening unit?

What are the risks of breast screening?

Frequently Asked Questions (FAQs)

Breast awareness

Benign breast disease

DCIS (Ductal Carcinoma
in Situ)

Diethylstilbestrol (DES) exposed women

Breast cancer

Quality assurance

Training

Programme statistics

Archived statistics bulletins

Research

Publications

Programme posters

Archive

Useful links

Home | Breast Screening | Cervical Screening | Bowel Cancer Screening | Prostate Cancer Risk Management | Breast Screening News | Contact NHS Screening ]

The national office can be contacted at:

NHS Cancer Screening Programmes
Fulwood House
Old Fulwood Road
SHEFFIELD S10 3TH

Tel: 0114 271 1060
Fax: 0114 271 1089
E-mail: [email protected]

Press and media enquiries should be made to:

NHS Cancer Screening Press Office
100 Gray's Inn Road
London
WC1X 8AL

Tel: 020 7400 4499
Fax: 020 7400 4481
E-mail: [email protected]

breastscreen/news/029.html
Designed and hosted by The Net Effect
©NHS Cancer Screening Programmes